Stocktoria

RetinalGenix Technologies Inc. RTGN

OTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-01-07

RetinalGenix Technologies Inc. statistics & valuation

Market cap$75.4M

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
202020212022202320242025
Shares outstanding
40.7M 41.2M 17.3M 17.6M 18.5M 18.8M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-3402.40% -44052.80% -1331289.10% -1340313.50% -28909.60% -11542.20% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.25 -$0.12 -$0.24 -$0.13 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-11542.2%-28909.6%-1340313.5%-1331289.1%-44052.8%-3402.4%
Return on equity105.5%295.4%148.7%366.1%469.0%2586.0%
Current ratio0.010.000.00———

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.